Efficacy

Comparable efficacy to desonide cream 0.05% at days 14 and 28 (P > .2) with a lower relapse rate (P < .02)¹

• Investigator global assessment (IGA) scores over time similar to desonide cream 0.05%¹

No statistically significant difference between Promiseb Cream and desonide cream 0.05%¹

(click image to enlarge)

Rapid efficacy with a lower relapse rate of seborrheic dermatitis

• 71% percent of day 14 responders (clear) in the Promiseb Cream group remained clear vs 14% in the desonide cream 0.05% group on day 28 (P < .02).¹
• Patients treated with Promiseb Cream whose symptoms cleared at day 14 were less likely to relapse by day 28 than patients using desonide cream 0.05% (P < .02).¹

Promiseb Cream is contraindicated in persons with a known hypersensitivity to any component of the formulation. Patients with a known allergy to shea butter or shea nut oil should consult their physician before using this product. Please see full prescribing information.